StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)

Close on Nov 17, 2026Market cap –P/E 48.4Yield –

argenx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

argenx's market cap was $61.14B on Nov 11, 2026, against $55.78B a year earlier. Over the last 5 years it ranged from $13.84B to $64.52B, with a median of $28.12B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$61.14B+18.9%
2025Dec 31, 2025$51.44B+39.9%
2024Dec 31, 2024$36.77B+72.8%
2023Dec 29, 2023$21.29B+2.1%
2022Dec 30, 2022$20.86B+15.9%
2021Dec 31, 2021$18.00B+43.1%
2020Dec 31, 2020$12.58B+117.8%
2019Dec 31, 2019$5.77B+86.8%
2018Dec 31, 2018$3.09B+143.3%
2017Dec 29, 2017$1.27B–

More argenx figures

See a number that looks wrong?